NRIX   $25.05  1.21% Market Closed After Close 25.06 0.04%

Nurix Therapeutics Inc
Total Cash 443.14M
totalCashPerShare 6.88
EBITDA -172.24M
Total Debt 28.82M
quickRatio 5.493
currentRatio 5.573
Total Revenue 62.30M
debtToEquity 7.774
Revenue/Share 1.101
ROA -0.25983
ROE -0.52331
grossProfits
freeCashflow -65.62M
operatingCashflow -96.10M
earningsGrowth
revenueGrowth -0.606
grossMargins -2.1538801
ebitdaMargins -2.76463
operatingMargins -4.0142198
profitMargins -2.64838
enterpriseValue 1.18B
forwardPE -9.176895
floatShares 50.88M
sharesOutstanding 64.41M
sharesShort 9.26M
sharesShortPriorMonth 9.32M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.04%
Short Ratio help_outline 15.25%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 5.76
Price To Book help_outline 4.41
earningsQuarterlyGrowth
netIncomeToCommon -165.00M
trailingEps -2.92%
forwardEps -2.77%
enterpriseToEbitda -6.87
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.69 3Q 2024
institutionsCount 245
lastUpdated Sept. 16, 2024, 7:58 p.m.